Overnight Digest: Stocks to keep an eye on December 12!

Mandar Wagh
/ Categories: Trending, Mindshare
Overnight Digest: Stocks to keep an eye on December 12!

Watch out for these stocks in Monday’s trading session!

Despite the upward trend in global indices, Indian benchmark indices ended the week lower, primarily due to over 2 per cent losses in the BSE IT and BSE Teck sectors. The BSE Sensex declined 0.62 per cent to 62,181 level at the close. The Nifty 50 index fell 0.61 per cent to a level of 18,496.  

Watch out for these stocks in Monday’s trading session -  

Lupin Ltd - Global pharmaceutical major Lupin today announced the addition of the approved generic version of PENNSAID (Diclofenac Sodium Topical Solution), 2 per cent w/w, from Horizon Pharma Therapeutics in the United States. The company sells its drugs all around the world, with the US serving as its main market.  

Vedanta Ltd - At its meeting, the board of directors reviewed and approved the offering for subscription of up to 8000 numbers of unsecured, rated, listed, redeemable, non-convertible debentures (NCDs) with a face value of Rs 10,00,000 each, totaling up to Rs 800 crore. Following the downturn in the metals sector, shares of Vedanta ended the Friday’s session 1.51 per cent lower.  

One 97 Communications - Given the company's current liquidity or financial condition, the management believes that a buyback may be beneficial to its shareholders and therefore it announced that a meeting will be held on December 13, 2022 to consider a proposal for a buyback of the company's fully paid-up equity shares. In a weak session on Friday, shares surged and ended the day more than 7 per cent higher.

Rate this article:
4.0

DSIJ MINDSHARE

Mkt Commentary20-Dec, 2024

Swing Trading22-Dec, 2024

IPO Analysis20-Dec, 2024

Mindshare20-Dec, 2024

IPO Analysis20-Dec, 2024

Knowledge

MF15-Nov, 2024

General15-Nov, 2024

MF14-Nov, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR